app

Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Dr Anna Schultze

Assistant Professor

United Kingdom

Jump to: Affiliations Teaching Research Publications
I am a pharmacoepidemiologist based in the Electronic Health Records (EHR) group researching drug and vaccine safety using large observational databases. Before joining LSHTM, I worked as an epidemiologist in the pharmaceutical industry where I led post-authorisation safety and comparative effectiveness studies, primarily using nationwide Scandinavian health registries. I completed a PhD in epidemiology at UCL in 2017, focusing on HIV drug resistance, and also hold an MSc in Epidemiology from LSHTM and a BSc in Human Sciences from UCL.

Affiliations
Department of Non-communicable Disease Epidemiology
Faculty of Epidemiology and Population Health

Teaching
I am a module organiser for Extended Epidemiology, and teach on Basic Epidemiology, the Professional Certificate course in Pharmacoepidemiology and Introduction to Health Data Science. My teaching covers a range of topics ranging from introductory epidemiology to reproducible programming/git. I also supervise a number of MSc students.

Research
I am broadly interested in how we can better use routinely collected data to study the effectiveness and safety of medications. My current research focuses on self-controlled study designs, specifically applied to COVID-19 vaccine safety and single-arm studies (long-term extensions of clinical trials). I have been involved in several broader studies of drug repurposing for COVID-19 and descriptive epidemiology using the OpenSAFELY platform. I'm particularly interested in reproducibility and open science, and also lead some meta-research on these practices in pharmacoepidemiology.
Research Area
Pharmacoepidemiology
Vaccines
Pharmacovigilance
Statistical methods
Research methodology

Selected Publications
SCHULTZE, A; Ju, S; Drysdale, M; Mu, G; Mitrani‐Gold, FS; Logie, J;
2025
Pharmacology Research & Perspectives
Muddiman, R; Aiello Battan, FI; TAZARE, J; SCHULTZE, A; Boland, F; Perez, T; Wei, L; Walsh, ME; Moriarty, F;
2025
Cold Spring Harbor Laboratory
MATTHEWMAN, J; SCHULTZE, A; BHASKARAN, K; Roberts, A; Denaxas, S; MANSFIELD, KE; LANGAN, SM;
2025
Cold Spring Harbor Laboratory
Bots, SH; Brown, J; WONG, AY S; Martin, I; DOUGLAS, I; Klungel, OH; SCHULTZE, A;
2025
Pharmacoepidemiology and drug safety
BOKERN, M; RENTSCH, CT; Quint, JK; Hunnicutt, J; DOUGLAS, I; SCHULTZE, A;
2025
Pharmacoepidemiology and drug safety
OpenSAFELY Collaborative,; WILLIAMSON, EJ; TAZARE, J; BHASKARAN, K; Walker, AJ; McDonald, HI; TOMLINSON, LA; Bacon, S; Bates, C; Curtis, HJ; Forbes, H; Minassian, C; Morton, CE; NIGHTINGALE, E; Mehrkar, A; Evans, D; Nicholson, BD; LEON, D; Inglesby, P; MacKenna, B; Cockburn, J; Davies, NG; Hulme, WJ; Morley, J; Douglas, IJ; ... Goldacre, B.
2024
Wellcome open research
The OpenSAFELY Collaborative,; WILLIAMSON, E; TAZARE, J; BHASKARAN, K; Walker, A; McDonald, H; TOMLINSON, L; Bacon, S; Bates, C; Curtis, H; Forbes, H; Minassian, C; Morton, C; NIGHTINGALE, E; Mehrkar, A; Evans, D; Nicholson, B; LEON, D; Inglesby, P; MacKenna, B; Cockburn, J; Davies, N; Hulme, W; Morley, J; DOUGLAS, I; ... Goldacre, B.
2024
Wellcome Open Res
COSTELLO, R; Waller, K; Smith, R; Mells, G; WONG, A; SCHULTZE, A; MAHALINGASIVAM, V; HERRETT, E; Zheng, B; Lin, L-Y; Mehrkar, A; Bacon, S; Goldacre, B; MacKenna, B; TAZARE, J; Rentsch, PhD, FISPE, C; TOMLINSON, L;
2024
Communications Medicine
MATTHEWMAN, J; SCHULTZE, A; STRONGMAN, H; BHASKARAN, K; Roberts, A; Denaxas, S; MANSFIELD, KE; LANGAN, SM;
2024
Nature communications
Mitrani-Gold, FS; Ju, S; Drysdale, M; SCHULTZE, A; Mu, G; Logie, J;
2024
Antimicrobial agents and chemotherapy
Anna Schultze

Contact

United Kingdom